Balance Sheet Data

Sorrento Therapeutics, Inc. (SRNE)

$0.3073

0.00 (0.00%)

Year
A/P
2018
Actual
2019
Actual
2020
Actual
2021
Actual
2022
Actual
2023
Projected
2024
Projected
2025
Projected
2026
Projected
2027
Projected
Total Cash 159.0322.5256.46126.8849.98212.22279.40367.84484.27637.56
Total Cash (%)
Account Receivables 4.3614.5115.5118.7124.4729.7639.1751.5767.9089.39
Account Receivables (%)
Inventories -3.361.838.119.989.6112.6516.6621.9328.88
Inventories (%)
Accounts Payable 13.8227.6324.7127.4147.5256.6474.5798.17129.25170.16
Accounts Payable (%)
Capital Expenditure -11.20-11.44-37.58-8.87-13.66-36.68-48.30-63.58-83.71-110.20
Capital Expenditure (%)



To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows) and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.